MPO and Alzheimer disease: For some of the biomarkers evaluated in the two papers, results were univocal: AD patients had a significant increase of serum ECP [47,48], significant decrease of serum vitamins A and E [25,26] and Zn [25,30], as well as quantities of serum MPO comparable to healthy controls [47,48].